Investment thesis
Sesamers tracks 1 portfolio company across 1 round. Its most recent tracked deal: Orakl Oncology, Nov 2026.
Portfolio
Past investments
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| Orakl Oncology Paris, France | Series A | Participant | Nov 2026 | €30.8M |